Denali Therapeutics

Denali Therapeutics is a biotechnology company focused on developing therapies for neurodegenerative diseases such as Alzheimer's, Parkinson's, and ALS. They make money by advancing their proprietary drug candidates through clinical trials and partnering with larger pharmaceutical companies for development and commercialization. Founded in 2015, Denali has made significant strides in understanding the genetic and molecular underpinnings of neurodegeneration, positioning itself as a leader in the field. Their innovative approach includes leveraging their Transport Vehicle (TV) technology to enhance drug delivery across the blood-brain barrier.

Recent Posts by Denali Therapeutics

1-20 of 209